Two Sigma Advisers
CDMO

Two Sigma Advisers’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Two Sigma Advisers’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-577,950
Closed -$7.14M – 2628
2024
Q4 		$7.14M Sell
577,950
-198,100
-26% -$2.27M 0.02% 582
2024
Q3 		$8.83M Buy
776,050
+173,200
+29% +$1.74M 0.02% 520
2024
Q2 		$4.3M Buy
602,850
+274,400
+84% +$2.1M 0.01% 827
2024
Q1 		$2.2M Buy
328,450
+147,800
+82% +$1.02M 0.01% 1173
2023
Q4 		$1.17M Buy
180,650
+145,190
+409% +$936K ﹤0.01% 1562
2023
Q3 		$335K Sell
35,460
-690
-2% -$8.3K ﹤0.01% 1948
2023
Q2 		$505K Sell
36,150
-54,600
-60% -$931K ﹤0.01% 1801
2023
Q1 		$1.7M Sell
90,750
-12,500
-12% -$205K ﹤0.01% 1355
2022
Q4 		$1.42M Sell
103,250
-15,700
-13% -$240K ﹤0.01% 1402
2022
Q3 		$2.27M Sell
118,950
-36,500
-23% -$665K 0.01% 1109
2022
Q2 		$2.37M Buy
155,450
+81,500
+110% +$1.21M 0.01% 1124
2022
Q1 		$1.51M Sell
73,950
-21,300
-22% -$434K ﹤0.01% 1413
2021
Q4 		$2.78M Sell
95,250
-119,700
-56% -$3.43M 0.01% 1026
2021
Q3 		$4.64M Buy
214,950
+103,000
+92% +$2.49M 0.01% 821
2021
Q2 		$2.87M Sell
111,950
-15,300
-12% -$327K 0.01% 1126
2021
Q1 		$2.32M Buy
127,250
+96,900
+319% +$1.61M 0.01% 1198
2020
Q4 		$350K Buy
+30,350
New +$277K ﹤0.01% 1995
2020
Q3 		– Sell
-45,851
Closed -$301K – 2667
2020
Q2 		$301K Buy
45,851
+8,414
+22% +$47K ﹤0.01% 2118
2020
Q1 		$191K Sell
37,437
-14,114
-27% -$85.4K ﹤0.01% 2184
2019
Q4 		$395K Buy
+51,551
New +$301K ﹤0.01% 1966
2018
Q4 		– Sell
-13,757
Closed -$94K – 2491
2018
Q3 		$94K Buy
+13,757
New +$81.6K ﹤0.01% 2154

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Two Sigma Advisers's CDMO Position: Q1 2025 in Review

Two Sigma Advisers sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 577,950 shares — an estimated $7.14M sold.

Two Sigma Advisers first reported a position in CDMO in Q3 2018 and held it in 21 quarters. The position peaked at $8.83M in Q3 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Two Sigma Advisers reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 577,950 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $7.14M.
  • Two Sigma Advisers first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2018 and held it in 21 quarters.
  • Two Sigma Advisers's Avid Bioservices, Inc. Common Stock position peaked at $8.83M in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Two Sigma Advisers's 13F filing for Q1 2025, filed 15 May 2025.